Psychemedics Corporation (PMD) News

Psychemedics Corporation (PMD): $6.65

0.05 (+0.76%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter PMD News Items

PMD News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest PMD News From Around the Web

Below are the latest news stories about Psychemedics Corp that investors may wish to consider to help them evaluate PMD as an investment opportunity.

Is Psychemedics Corporation's (NASDAQ:PMD) Stock On A Downtrend As A Result Of Its Poor Financials?

With its stock down 16% over the past three months, it is easy to disregard Psychemedics (NASDAQ:PMD). Given that stock...

Yahoo | February 16, 2022

Psychemedics Corporation Declares Cash Dividend

ACTON, Mass., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world’s largest provider of hair testing for drugs of abuse, today announced that it has declared a cash dividend of $0.05 per share to be paid on December 30th, 2021 to shareholders of record as of December 20th, 2021. As the record shows, the Company paid 94 consecutive dividends (23 ½ years) through the first quarter of 2020, even during the financial crisis in 2008. However, because of the COVID pandem

Yahoo | December 10, 2021

Returns On Capital At Psychemedics (NASDAQ:PMD) Paint A Concerning Picture

When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...

Yahoo | November 16, 2021

Psychemedics Corporation Reports Stronger Revenue, Operating Profit and Earnings Growth in Third Quarter 2021

ACTON, Mass., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world’s largest provider of hair testing for drugs of abuse, today announced financial results for the third quarter ended September 30, 2021. The Company’s revenue for the quarter ended September 30, 2021, was $6.7 million versus $5.2 million for the quarter ended September 30, 2020, an increase of 29%. Net income for the quarter ended September 30, 2021, was $0.7 million or $0.13 per diluted share, versu

Yahoo | November 12, 2021

Psychemedics Corporation Reports Stronger Second Quarter 2021 Financial Results

ACTON, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world’s largest provider of hair testing for drugs of abuse, today announced financial results for the second quarter ended June 30, 2021. The Company’s revenue for the quarter ended June 30, 2021, was $6.1 million versus $3.3 million for the quarter ended June 30, 2020, an increase of 85%. Net income for the quarter ended June 30, 2021, was $0.1 million or $0.02 per diluted share, versus net loss of $2.1

Yahoo | August 10, 2021

Did Psychemedics Corporation (NASDAQ:PMD) Insiders Buy Up More Shares?

We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is that...

Yahoo | July 1, 2021

Is Psychemedics Corp. (PMD) A Good Stock To Buy?

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn’t the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F filings […]

Yahoo | June 14, 2021

Psychemedics Corporation Reports First Quarter 2021 Financial Results

ACTON, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world’s largest provider of hair testing for drugs of abuse, today announced financial results for the first quarter ended March 31, 2021. The Company’s revenue for the quarter ended March 31, 2021 was $5.7 million versus $7.5 million for the quarter ended March 31, 2020, a decrease of 24%. Net income for the quarter ended March 31, 2021 was $0.1 million or $0.01 per diluted share, versus net loss of $0.2 million or ($0.03) per diluted share, for the comparable period last year, an increase of $0.04 per diluted share. Raymond C. Kubacki, Chairman and Chief Executive Officer, stated: "We continued to see improvement in total revenues, month-to-month and quarter-to-quarter, since the COVID-19 shutdow...

Yahoo | May 10, 2021

Psychemedics Corporation Reports Fourth Quarter and Full Year 2020 Financial Results

ACTON, Mass., March 23, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world’s largest provider of hair testing for drugs of abuse, today announced fourth quarter and full year financial results for the period ended December 31, 2020. The Company's revenue for the year ended December 31, 2020 was $21.4 million versus $37.7 million for the twelve months ended December 31, 2019, a decrease of 43%. Net loss for the twelve months ended December 31, 2020 was $3.9 million or $0.70 per diluted share, versus net income of $1.5 million or $0.28 per diluted share, for the comparable period last year. The Company’s revenue for the quarter ended December 31, 2020 was $5.3 million versus $8.7 million for the quarter ended December 31, 2019, a decrease of 39%. Net loss for the qu...

Yahoo | March 23, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6484 seconds.